… effective antiviral therapy for COVID-19 is … antiviral therapies for COVID-19, including
research spanning preclinical and clinical drug development efforts, with an emphasis on antiviral …

… SARS-CoV-2 strains from COVID-19 patients in Norway. We showed that UVC and high
temperatures destroyed SARS-CoV-2, … We developed a neutralization assay using SARS-CoV-2 …

… hundred percent” effective antiviral therapy against SARS-CoV-2/COVID-19 and that further
… , which may not be based on a unique drug but rather on a combination of active antivirals. …

… identify antivirals to curtail the COVID-19 pandemic. Herein, we report the sensitivity of
SARS-CoV-2 … These results suggest that SARS-CoV-2 is more sensitive than many other human …

… Specifically, we assessed the potential antiviral activity of 11,987 compounds against
SARS-CoV-2 in Vero E6 cells. The assay, conducted at a final compound concentration of 5 μM …

… drugs with antiviral effects against SARS‐CoV‐2 in cell‐based assays as those substances
offer great opportunities for a treatment early in the course of COVID‐19 by inhibition of viral …

… COVID-19 (6). However, the administration of a potent and specific antiviral against SARS-CoV-2 …
and prior to viral peak could actually stop or avoid the pathogenic course of COVID-19. …

… Here, we report the potent antiviral activity of PF-00835231 against SARS-CoV-2 in human
lung epithelial cells and a model of polarized human airway epithelial cultures (HAEC). In our …

… COVID-19 variant. Thus, there is a race to find treatment alternatives. We contend that oral
small molecule antivirals that halt SARS-CoV-2 … is required, oral antivirals offer treatments in …

… for SARS-CoV-2 infection. … antiviral strategies targeting viral protease, RdRp and spike
glycoprotein, that have been proposed to cope with the infection sustained by SARS-CoV-2 and …